The Child Health Advantage program offers discounted pricing on the Novartis vaccine portfolio.
As of April 1, 2011, Child Health Advantage Members receive the best pricing in the nation on the Menveo vaccine. Members are able to receive 13% off list price when ordering direct, plus an additional 2% discount for prompt pay. Please contact us for more information.
The 2013 recommended childhood and adolescent vaccine schedules have been revised.
GlaxoSmithKline (GSK) has started offering up front pricing to members who meet certain performance requirements.
Beginning March 1, 2013, GlaxoSmithKline (GSK) will accept and fulfill orders for the Menveo vaccine manufactured by Novartis.